Li-Fraumeni syndrome has the risk of development of:
**Core Concept**
Li-Fraumeni syndrome is a rare, autosomal dominant genetic disorder characterized by a high risk of developing various cancers, primarily due to mutations in the TP53 tumor suppressor gene. This gene plays a crucial role in regulating cell growth, DNA repair, and apoptosis.
**Why the Correct Answer is Right**
The TP53 gene acts as a tumor suppressor by preventing uncontrolled cell growth and DNA damage. Mutations in this gene lead to a loss of its function, resulting in increased susceptibility to various cancers, including breast cancer, brain tumors, osteosarcoma, and adrenocortical carcinoma. The Li-Fraumeni syndrome is associated with a high lifetime risk of developing these cancers, often at an early age.
**Why Each Wrong Option is Incorrect**
**Option A:** Although Li-Fraumeni syndrome is associated with a high risk of developing various cancers, it is not primarily characterized by an increased risk of leukemia. Leukemia is more commonly associated with other genetic syndromes, such as Down syndrome or Fanconi anemia.
**Option B:** While Li-Fraumeni syndrome does increase the risk of developing brain tumors, it is not the primary cancer associated with this syndrome. Oligodendrogliomas are more commonly associated with Li-Fraumeni syndrome.
**Option C:** Li-Fraumeni syndrome is not primarily characterized by an increased risk of colon cancer. Although some individuals with Li-Fraumeni syndrome may develop colon cancer, it is not a hallmark of this syndrome.
**Clinical Pearl / High-Yield Fact**
Individuals with Li-Fraumeni syndrome often develop multiple primary cancers, and a high index of suspicion is necessary to identify these cases. A family history of early-onset cancers, particularly breast cancer or brain tumors, should prompt screening for Li-Fraumeni syndrome.
**Correct Answer: D. Breast cancer, brain tumors, osteosarcoma, and adrenocortical carcinoma.**